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ASSESSMENT OF THE HEALTH-RELATED QUALITY OF LIFE IMPACT OF
EUFLEXXA (1% SODIUM HYALURONATE) USING THE SHORT FORM
(SF)-36 DATA COLLECTED IN A RANDOMIZED CLINICAL TRIAL
H.T. Hatoum y, J.E. Rosen z, A.L. Fierlinger x, S.-J. Lin k, R.D. Altman {. yCtr.
for Pharmacoeconomic Res., Univ. of IL, Chicago, IL, USA; zDept. of
Orthopaedics & Rehabilitation, NY Hosp. Queens, Queens, NY, USA;
x Ferring Pharmaceuticals Inc., Parsippany, NJ, USA; kUniv. of Illinois at
Chicago, Coll. of Pharmacy, Chicago, IL, USA; {Univ. of California, Los
Angeles, Los Angeles, CA, USA
Purpose: Viscosupplementation with intra-articular (IA) injection of
hyaluronic acid (HA) is used to help relieve knee pain in patients with
osteoarthritis (OA), but littledata isavailable forpatient reportedoutcomes
of IA-HA therapy. The FLEXX trial, a 26-week, double-blind, randomized,
parallel-group placebo-controlled trial assessed the efﬁcacy and safety of
bioengineered 1% sodium hyaluronate (IA-BioHA) vs saline (IA-SA) for OA
knee pain, and was followed by a 26-week open-label Extension Study to
evaluate the safety of IA-BioHA reinjection. Here we investigate health-
related quality of life (HRQoL) measures using the SF-36 in patients with
OA of the knee enrolled in the FLEXX Trial and Extension Study.
Methods: SF-36 scores were collected at baseline, week 26, and week
52 of the Flexx Trial and Extension Study. Correlations between the SF-
36 scores and the clinical outcomes of the 50-foot walk test (100 mm
visual analog scale), Western Ontario McMaster Universities Osteoar-
thritis Index (WOMAC) scores, and the OMERACT-OARSI responder
index were also investigated.
Results: Baseline SF-36 scores for patients indicated signiﬁcant physical
limitations relative to the US population (aged 55-64 years) as well as
norms for an OA population. Both the IA-BioHA and IA-SA treatment
groups experienced signiﬁcant improvements over baseline in SF-36
domains measuring physical ability at weeks 12 and 26 posttreatment.
Improvements in the form of effect size at week 26 were: 0.49 vs 0.35 in
physical functioning (PF), 0.39 vs 0.27 in role physical (RP), 0.39 vs 0.31
in bodily pain (BP), and 0.54 vs 0.32 in physical component summary
(PCS) scores in the IA-BioHA and IA-SA groups, respectively. Patients
treated with IA-BioHA experienced statistically signiﬁcant improve-
ment over the IA-SA group at week 26 in PCS (P<0.05) after controlling
for other covariates. Changes in several physical domains of the SF-36
signiﬁcantly correlated with changes in the other outcome measures,
with the highest correlation between the WOMAC disability subscale
and the PCS (r¼-0.58, P<0.001). At the end of the FLEXX Trial therewere
169 responders and 85 non-responders in the IA-BioHA group per
OARSI criteria. Compared to non-responders, responders experienced
improvement in all SF-36 scores, with statistically signiﬁcant differ-
ences for PF, RP, BP, social functioning, role-emotional and PCS
(P¼<0.05). Several physical function domains of the SF-36 were found
to discriminate treatment response: i,e., changes between the SF-36
scores at week 26 continued to improve through week 52, with
a signiﬁcantly lower bodily pain domain (P¼0.014) in patients who
received IA-BioHA in both the FLEXX Trial and the Extension Study.
Conclusions: Patients treated with IA-BioHA in the FLEXX Trial experi-
enced signiﬁcantly greater improvement in physical functioning as
measuredby the SF-36PCS score compared topatients treatedwith IA-SA.
Also, IA-BioHA resulted in clinically meaningful differences in reducing
patients’physical disability. Patientswhoreceiveda repeatedcourseof IA-
BioHA treatment afterweek 26 experienced further improvement in their
physical ability with a signiﬁcant reduction in bodily pain.
466
OSTEOARTHRITIS OF THE KNEE AT 6-YEAR FOLLOW-UP AND THEIR
PROGNOSTIC FACTORS IN ADULTS WITH NON-TRAUMATIC KNEE
COMPLAINTS IN GENERAL PRACTICE
M. Kastelein, G. van de Zande, J. Verhaar, B. Koes, P. Luijsterburg, S.
Bierma-Zeinstra. Erasmus MC, Erasmus Univ. Med. Ctr., Rotterdam, The
Netherlands
Purpose: To investigate how to identify which patients with knee
complaints in general practice will develop knee osteoarthritis (OA) at
6-year follow-up.
Methods: Adults (aged >35 years) with incident non-traumatic knee
complaints (n¼549)were followed for 6years for thepresenceof kneeOA,
according to the clinical AmericanCollege of Rheumatology (ACR) criteria.
In addition, at 6-year follow-up the presence of knee OA was identiﬁed
based on a radiograph and the clinical & radiographic ACR criteria.Multivariable logistic regression analysis was used to identify baseline
prognostic factors associated with the presence of knee OA at 6-year
follow-up and the area under the receiver-operating curve (AUC) was
calculated.
Results: According to the clinical ACR criteria, at baseline and at 1 and 6-
year follow-up, 63%, 44% and 39% of the patients suffered from knee OA,
respectively. In total, 45% of the patients switched from ACR positive/
negative at the different follow-up points. Also, at 6-year follow-up, 39%
and 31% of the patients suffered from knee OA based on the radiographs
and the clinical & radiographic ACR criteria, respectively. Of the clinical
ACR criteria, only age was independent signiﬁcantly related with clinical
and radiographic knee OA at 6-year follow-up. In addition, a body mass
index of >27, self-reported swollen knee, history of non-traumatic knee
complaints and self-reported instability of the knee were also indepen-
dent signiﬁcantly related with clinical and radiographic knee OA (AUC of
0.81). Results from physical examination had no additional value.
Conclusions: Of patients with non-traumatic knee complaints seen in
general practice, 31%-39% suffered from knee OA at 6-year follow-up.
The clinical ACR criteria for knee OA are not appropriate for predicting
which patients with knee complaints in general practice will develop
knee OA at follow-up. For this, ﬁve baseline patient and symptom
characteristics seemed more appropriate.
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IS RADIOGRAPHIC KNEE OSTEOARTHRITIS MORE SEVERE WHEN
HAND OSTEOARTHRITIS IS PRESENT AND CONVERSELY? A CROSS-
SECTIONAL STUDY IN 1371 KNEE OSTEOARTHRITIS PATIENTS
E. Maheu y, C.C. Cadet z, F. Berenbaum y. yRheumatology, St-Antoine
Hosp., Paris, France; zCabinet de Rhumatologie, Paris, France
Background: The association between hand (HOA) and knee osteoar-
thritis (KOA) has been questioned. Current evidence is contradictory.
Objectives: To study the prevalence of radiographic HOA in a large KOA
population, and its cross-sectional association to knee OA radiographic
severity.
Methods: Baseline data were obtained from an international 3-year
prospective, multicenter, randomized, controlled trial comparing the
structural effect of strontium ranelate to placebo in KOA. Inclusion
criteria were: a diagnosis of OA according to ACR criteria, knee pain
>40mm on a visual analog scale, OA at medial compartment with
a Kellgren-Lawrence (KL) grade 2 or 3and a minimal joint space width
(JSW) of 2.5 to 5mm. Fixed-ﬂexion postero-anterior (PA) radiographs of
both knees in standing position every year and PA radiographs of each
hand at baseline and endpoint were performed. Minimal JSW was
centrally measured using a semi-automated standardized method.
Hand radiographs were graded by 2 readers using KL (range 0-128),
Kallman (0-204) and Verbruggen scoring methods. Radiographic HOA
was deﬁned as 2 or more joints at a KL2 or more. Statistics: Student T
test, and Pearson correlation coefﬁcient. Only the 1371 patients having
at least 2 knee radiographs were analyzed.
Results: 1360 patients had hand radiographs at baseline. 999 (73%) had
HOA (HOA+). InHOA+, themeanagewas 64 years, 71%were female,mean
bodymass index29.6.HOA+wereolder (5yrs),withahigherpercentageof
female (p¼0.04), with no difference on BMI compared to non HOA
patients (p¼0.12). Mean knee JSW was 3.44 versus 3.66mm (p<0.001),
and there was slightly more KL3 knees (40% vs 34%; p¼0.047) in HOA+
compared to non HOA respectively. Conversely, global hand KL and Kall-
manscoreswerehigher inKL3KOApatients (22.5 vs20.2; p¼0.01 and27.0
vs 23.6; p¼0.02respectively), compared to KL2 patients. There was no
difference for the Verbruggen score (14.7 vs 13.6, p¼0.32). Pearson anal-
yses did not showed linear correlations between knee JSW and hand KL
score (r¼0.123) or between knee and hand KL scores (r¼0.085).
Conclusions: Our data indicates a very high prevalence of radiographic
HOA in a symptomatic KOA population, much more than expected. KOA
is radiographically more severe in case of HOA. Conversely, HOA is more
severe in the more severe KOA patients (KL3).
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STANCE AND SINGLE SUPPORT TIME ASYMMETRY IDENTIFY
UNILATERAL KNEE OA AND THE INVOLVED LIMB: THE
MULTICENTER OSTEOARTHRITIS STUDY
